154 related articles for article (PubMed ID: 35106316)
1. Patients With Serious Injection Drug Use-Related Infections who Experience Patient-Directed Discharges on Oral Antibiotics Have High Rates of Antibiotic Adherence but Require Multidisciplinary Outpatient Support for Retention in Care.
Lewis S; Liang SY; Schwarz ES; Liss DB; Winograd RP; Nolan NS; Durkin MJ; Marks LR
Open Forum Infect Dis; 2022 Feb; 9(2):ofab633. PubMed ID: 35106316
[TBL] [Abstract][Full Text] [Related]
2. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team.
Serota DP; Tookes HE; Hervera B; Gayle BM; Roeck CR; Suarez E; Forrest DW; Kolber MA; Bartholomew TS; Rodriguez AE; Doblecki-Lewis S
Ann Med; 2021 Dec; 53(1):1960-1968. PubMed ID: 34726095
[TBL] [Abstract][Full Text] [Related]
3. Medications for opioid use disorder associated with reduced readmissions for patients with severe injection-related infections: A matched cohort study.
Robertson NM; Mangino AA; South AM; Fanucchi LC
J Subst Use Addict Treat; 2024 May; 160():209298. PubMed ID: 38262559
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Partial Oral Antibiotic Treatment for Persons Who Inject Drugs and Are Hospitalized With Invasive Infections.
Marks LR; Liang SY; Muthulingam D; Schwarz ES; Liss DB; Munigala S; Warren DK; Durkin MJ
Clin Infect Dis; 2020 Dec; 71(10):e650-e656. PubMed ID: 32239136
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs.
Wildenthal JA; Atkinson A; Lewis S; Sayood S; Nolan NS; Cabrera NL; Marschall J; Durkin MJ; Marks LR
Clin Infect Dis; 2023 Feb; 76(3):487-496. PubMed ID: 36052413
[TBL] [Abstract][Full Text] [Related]
6. A Study Protocol to Increase Engagement in Evidence Based Hospital and Community Based Care Using a Serious Injection Related Infections (SIRI) Checklist and Enhanced Peer for Hospitalized PWID (ShaPe).
Baldwin M; Jeziorski M; Parman M; Gagnon K; Nichols MA; Bradford D; Crockett K; Eaton E
Res Sq; 2023 Jun; ():. PubMed ID: 37333109
[TBL] [Abstract][Full Text] [Related]
7. Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study.
Hervera B; Seo G; Bartholomew TS; Chueng TA; Suarez E; Forrest DW; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Serota DP
Addict Sci Clin Pract; 2023 Feb; 18(1):8. PubMed ID: 36747268
[TBL] [Abstract][Full Text] [Related]
8. Integrated Infectious Disease and Substance Use Disorder Care for the Treatment of Injection Drug Use-Associated Infections: A Prospective Cohort Study With Historical Control.
Serota DP; Rosenbloom L; Hervera B; Seo G; Feaster DJ; Metsch LR; Suarez E; Chueng TA; Hernandez S; Rodriguez AE; Tookes HE; Doblecki-Lewis S; Bartholomew TS
Open Forum Infect Dis; 2023 Jan; 10(1):ofac688. PubMed ID: 36632415
[TBL] [Abstract][Full Text] [Related]
9. Value of Packaged Testing for Sexually Transmitted Infections for Persons who Inject Drugs Hospitalized With Serious Injection-Related Infections.
Marks LR; Reno H; Liang SY; Schwarz ES; Liss DB; Jiang L; Nolan NS; Durkin MJ
Open Forum Infect Dis; 2021 Nov; 8(11):ofab489. PubMed ID: 34926711
[TBL] [Abstract][Full Text] [Related]
10. Mortality, morbidity, and cardiac surgery in Injection Drug Use (IDU)-associated versus non-IDU infective endocarditis: The need to expand substance use disorder treatment and harm reduction services.
Thakarar K; Rokas KE; Lucas FL; Powers S; Andrews E; DeMatteo C; Mooney D; Sorg MH; Valenti A; Cohen M
PLoS One; 2019; 14(11):e0225460. PubMed ID: 31770395
[TBL] [Abstract][Full Text] [Related]
11. Evaluating Differences in Opioid and Stimulant Use-associated Infectious Disease Hospitalizations in Florida, 2016-2017.
Serota DP; Bartholomew TS; Tookes HE
Clin Infect Dis; 2021 Oct; 73(7):e1649-e1657. PubMed ID: 32886747
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Management of invasive infections among people who Use drugs (EMU): protocol for a prospective, multicentre cohort study.
Attwood LO; Bryant M; Lee SJ; Vujovic O; Higgs P; Doyle JS; Stewardson AJ;
BMJ Open; 2023 Apr; 13(4):e070236. PubMed ID: 37012020
[TBL] [Abstract][Full Text] [Related]
13. Care cascade for patients with opioid use disorder and serious injection related infections.
Upadhyaya A; Marks LR; Schwarz ES; Liang SY; Durkin MJ; Liss DB
Toxicol Commun; 2021; 5(1):6-10. PubMed ID: 33733021
[TBL] [Abstract][Full Text] [Related]
14. Outcomes According to Discharge Location for Persons Who Inject Drugs Receiving Outpatient Parenteral Antimicrobial Therapy.
D'Couto HT; Robbins GK; Ard KL; Wakeman SE; Alves J; Nelson SB
Open Forum Infect Dis; 2018 May; 5(5):ofy056. PubMed ID: 29766017
[TBL] [Abstract][Full Text] [Related]
15. A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections.
Marks LR; Munigala S; Warren DK; Liss DB; Liang SY; Schwarz ES; Durkin MJ
J Infect Dis; 2020 Sep; 222(Suppl 5):S513-S520. PubMed ID: 32877547
[TBL] [Abstract][Full Text] [Related]
16. Risk of New Bloodstream Infections and Mortality Among People Who Inject Drugs With Infective Endocarditis.
Tan C; Shojaei E; Wiener J; Shah M; Koivu S; Silverman M
JAMA Netw Open; 2020 Aug; 3(8):e2012974. PubMed ID: 32785635
[TBL] [Abstract][Full Text] [Related]
17. Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014-18.
Jo Y; Nosal R; Vittori A; Cordova L; Vandever C; Alvarez C; Bartholomew TS; Tookes HE
Addiction; 2021 Aug; 116(8):2127-2134. PubMed ID: 33394516
[TBL] [Abstract][Full Text] [Related]
18. In-Hospital Illicit Drug Use and Patient-Directed Discharge: Barriers to Care for Patients With Injection-Related Infections.
Eaton EF; Westfall AO; McClesky B; Paddock CS; Lane PS; Cropsey KL; Lee RA
Open Forum Infect Dis; 2020 Mar; 7(3):ofaa074. PubMed ID: 32258203
[TBL] [Abstract][Full Text] [Related]
19. Partial-Oral Antibiotic Therapy for Bone and Joint Infections in People With Recent Injection Drug Use.
Yang WT; Dombrowski JC; Glick SN; Kim HN; Beieler AM; Lan KF; Dhanireddy S
Open Forum Infect Dis; 2023 Jan; 10(1):ofad005. PubMed ID: 36726538
[TBL] [Abstract][Full Text] [Related]
20. Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs.
Gonzalez PL; Rappo U; Akinapelli K; McGregor JS; Puttagunta S; Dunne MW
Drugs Context; 2018; 7():212559. PubMed ID: 30574170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
